Skip to main navigation Skip to search Skip to main content

RIPRETINIB DEMONSTRATES COMPARABLE EFFICACY AND FEWER SIDE EFFECTS COMPARED TO SUNITINIB IN PATIENTS WITH GIST PREVIOUSLY TREATED WITH IMATINIB

Press/Media

PeriodJan 24 2022

Media coverage

1

Media coverage

  • TitleRIPRETINIB DEMONSTRATES COMPARABLE EFFICACY AND FEWER SIDE EFFECTS COMPARED TO SUNITINIB IN PATIENTS WITH GIST PREVIOUSLY TREATED WITH IMATINIB
    Media name/outletStates News Service
    Country/TerritoryUnited States
    Date01/24/22
    PersonsMargaret von Mehren
View all 1
View less